| ‘Dopamine agonist Phobia’in Parkinson’s disease: when does it matter? Implications for non-motor symptoms and personalized medicine S Rota, I Boura, L Batzu, N Titova, P Jenner, C Falup-Pecurariu, ... Expert Review of Neurotherapeutics 20 (9), 953-965, 2020 | 8 | 2020 |
| ‘Levodopa Phobia’: a review of a not uncommon and consequential phenomenon N Titova, O Levin, E Katunina, K Ray Chaudhuri npj Parkinson's Disease 4 (1), 31, 2018 | 28 | 2018 |
| ‘Sleep attacks’ or ‘unintended sleep episodes’ occur with dopamine agonists: is this a class effect? KR Chaudhuri, S Pal, C Brefel-Courbon Drug safety 25, 473-483, 2002 | 63 | 2002 |
| " Dozing off" in the car and Excessive Daytime Sleepiness (EDS) in Parkinson's disease C Borley, C Sportelli, K Chaudhuri EUROPEAN JOURNAL OF NEUROLOGY 27, 642-642, 2020 | | 2020 |
| [18F] FDOPA uptake in the raphe nuclei complex reflects serotonin transporter availability. A combined [18F] FDOPA and [11C] DASB PET study in Parkinson's disease N Pavese, BS Simpson, V Metta, A Ramlackhansingh, KR Chaudhuri, ... Neuroimage 59 (2), 1080-1084, 2012 | 59 | 2012 |
| 1.014 Non-motor symptoms in akinesia dominant versus other phenotypes in Parkinson's disease (PD): results from the international PD non-motor symptoms scale study Y Naidu, D Contrafatto, P Martinez-Martin, KR Chaudhuri Parkinsonism & Related Disorders 13, S31, 2007 | 2 | 2007 |
| 1.060 SLEEP REGULATORY CENTRES DYSFUNCTION IN PARKINSON'S DISEASE PATIENTS WITH EXCESSIVE DAYTIME SLEEPINESS. AN IN VIVO PET STUDY N Pavese, V Metta, BS Simpson, TA Marphy, A Ramlackhansingh, ... Parkinsonism and Related Disorders, S24-S25, 2012 | 20 | 2012 |
| 1.152 Dribbling of saliva in Parkinson's disease: Clinical correlations H Lewis, P Martinez-Martin, KR Chaudhuri Parkinsonism and Related Disorders, S47, 2007 | | 2007 |
| 1.284 Daytime fatigue in idiopathic restless legs syndrome: Evaluation with Parkinson's fatigue scale Y Naidu, V Metta, S Tluk, J Roomi, O Bernadette, KR Chaudhuri Parkinsonism and Related Disorders, S72, 2007 | | 2007 |
| 1.297 Rotigotine transdermal patch is effective in the treatment of idiopathic RLS: Results of a 6 month, multicenter, double blind, placebo controlled trial in Europe C Trenkwalder, KR Chaudhuri, LF Strambi, D Garcia-Borreguero, B Hoegl, ... Parkinsonism and Related Disorders, S75-S76, 2007 | 1 | 2007 |
| 1) Odagiri H., Baba T., Nishio Y., Iizuka O., Matsuda M., Inoue K., Kikuchi A., Hasegawa T., Aoki M., Takeda A., Taki Y., Mori E., On the Utility of MIBG SPECT/CT in Evaluating … KR Chaudhuri, E Tolosa, AHV Schapira, W Poewe Group 29, 857-867, 2014 | | 2014 |
| 12th Clinical Autonomic Research Society Meeting, the Wellcome Trust Building, London, November 1995 KR Chaudhuri Clinical Autonomic Research 6 (4), 245-245, 1996 | | 1996 |
| 135 Hyperhidrosis as an identifier in parkinson’s disease subtyping D van Wamelen, V Leta, A Podlewska, W Yi-Min, K Krbot, E Jaakkola, ... Journal of Neurology, Neurosurgery and Psychiatry 90 (12), e38, 2019 | | 2019 |
| 193 Sleep dysfunction in Parkinson’s disease KR Chaudhuri Parkinson's Disease in the Older Patient, 193-218, 0 | | |
| 2.135 CHARACTERISING NON MOTOR PATTERNS OF EARLY MORNING OFF PERIODS IN PARKINSON'S DISEASE: AN INTERNATIONAL STUDY A Rizos, TK Kozul, A Martin, I Koch, S Tluk, B Kessel, P Martinez-Martin, ... Parkinsonism and Related Disorders, S110, 2012 | 1 | 2012 |
| 2.248 Improvement of nocturnal symptoms in patients with idiopathic Parkinson's disease using rotigotine transdermal C Trenkwalder, KR Chaudhuri, B Boroojerdi Parkinsonism and Related Disorders, S111, 2007 | | 2007 |
| 2.253 INTRAJEJUNAL LEVODOPA INFUSION IN THE UK: COMPARATIVE REVIEW OF MOTOR AND NON-MOTOR EFFECTS IN TREATED VERSUS UNTREATED ADVANCED PARKINSON'S PATIENTS P Reddy, P Martinez-Martin, A Rizos, A Martin, GC Faye, I Forgacs, ... Parkinsonism and Related Disorders, S128, 2012 | | 2012 |
| 239 New de novo mutation in CACNA1a gene leading to episodic ataxia type 2 A Coulden, K Wu, D Joe, S Watkins, KR Chaudhuri, L Sztriha Journal of Neurology, Neurosurgery & Psychiatry 93 (6), A82-A82, 2022 | | 2022 |
| 24-hour symptom control with adjunctive ropinirole prolonged release in patients with advanced Parkinson's disease (PD) and significant nocturnal symptoms F Stocchi, J Cooper, K Rolfe, A Lipschitz, KR Chaudhuri EUROPEAN JOURNAL OF NEUROLOGY 17, 116-116, 2010 | | 2010 |
| 3. IS. 3.2 Treating Parkinson's symptoms 24 hours–Day and night KR Chaudhuri Parkinsonism and Related Disorders, S190, 2007 | | 2007 |
Richard G BrownKing's College London在 kcl.ac.uk 的电子邮件经过验证
